Ardent Health vs Surgery Partners
ARDT and SGRY side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ARDT and SGRY compare
Surgery Partners is the larger company, worth 1.4 times as much as Ardent Health ($3.5B against $2.5B).
Surgery Partners grew revenue faster over the last twelve months (4.0% versus 3.3% for Ardent Health).
Ardent Health keeps more of each dollar of sales as profit, with a net margin of 1.2% compared with −2.6% at Surgery Partners.
Ardent Health scores higher on the StockData Score (7 against 5 for Surgery Partners), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ARDT | SGRY |
|---|---|---|
| Size and price | ||
| Market cap | $2.5B | $3.5B |
| Share price | $17.75 | $26.85 |
| Change, 1 year | 97.0% | 75.7% |
| Change, 5 years | – | −38.6% |
| Beta (5Y) | −0.20 | 1.06 |
| Employees | 25K | 16K |
| StockData Score | ||
| Total score | 7 (better) | 5 |
| Valuation score | 2 (better) | 1 |
| Growth score | 1 (better) | 0 |
| Performance score | 2 | 2 |
| Health score | 2 | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 32.3× | – |
| P/S | 0.4× (better) | 1.0× |
| P/B | 1.9× (better) | 2.1× |
| EV/EBITDA | 8.8× (better) | 15.1× |
| P/FCF | – | 18.7× |
| FCF yield | – | 5.3% |
| Fair value | $18.37 | $24.21 |
| Margin of safety | 3.4% (better) | −10.9% |
| Growth | ||
| Revenue growth (TTM) | 3.3% | 4.0% (better) |
| Revenue growth, 5Y average | – | 12.2% |
| Net income growth (TTM) | −69.3% | – |
| EPS growth (TTM) | −69.6% | – |
| Profitability | ||
| Operating margin | – | 11.4% |
| Net margin | 1.2% (better) | −2.6% |
| FCF margin | – | 5.6% |
| Return on equity | 6.0% (better) | −5.2% |
| Return on invested capital | – | 5.9% |
| Financial health | ||
| Debt / equity | 0.82 (better) | 2.25 |
| Net debt / EBITDA | 1.01 (better) | 6.30 |
| Current ratio | 2.10 (better) | 1.95 |
| Altman Z-score | 2.03 (better) | 0.93 |
| Piotroski F-score | 6 (better) | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 76.9% | 121% |
| Held by insiders | 2.7% | 85.9% |
| Insider net buying, 12 months | $186K (better) | −$979K |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 2.5% | 48.6% |
Go deeper
- ARDT stock overview
- ARDT income statement
- ARDT valuation and score
- SGRY stock overview
- SGRY income statement
- SGRY valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.